Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117331) titled 'Lymphoma Lesion Distribution Characteristics and Scan Range Optimization Based on Total-Body PET/CT' on Jan. 22.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Lymphoma
Intervention:
Regional scan group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-23
Target Sample Size: Regional scan group:1000;Scan range comparison group:9000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299684
Disclaimer: Curated by HT...